Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Ichi Harashima

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Regulatory Toxicology and Pharmacology : RTP|January 25, 2006
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trialHideyuki Ikematsu, Kenjiro Nakamura, Shin-ichi Harashima, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Case report; a case of gastorinoma with subclinical insulinoma presenting repeated episodes of hypoglycemic attack]Kimitaka Shibue, Shin-Ichi Harashima, Yuji Nakamoto, et al.
Scientific Reports|April 12, 2017
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretionYu Wang, Shin-Ichi Harashima, Yanyan Liu, et al.
Journal of Neuroscience Research|June 15, 2011
Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter releaseShin-ichi Harashima, Yu Wang, Takahiko Horiuchi, et al.
BMJ Case Reports|July 17, 2012
Marchiafava-Bignami disease-like lesions due to central nervous system lupusYoichiro Kashiwagi, Takahiko Horiuchi, Chie Harashima, et al.
Journal of Diabetes Science and Technology|October 3, 2015
Once Daily Self-Monitoring of Blood Glucose (SMBG) Improves Glycemic Control in Oral Hypoglycemic Agents (OHA)-Treated Diabetes: SMBG-OHA Follow-Up StudyShin-Ichi Harashima, Akiko Nishimura, Kaori Ikeda, et al.
Cardiovascular Diabetology|June 19, 2016
Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitusNobuya Inagaki, Shin-Ichi Harashima, Nobuko Maruyama, et al.
Journal of Diabetes Investigation|May 21, 2014
Sorting nexin 19 regulates the number of dense core vesicles in pancreatic β-cellsShin-Ichi Harashima, Takahiko Horiuchi, Yu Wang, et al.
Diabetes, Obesity & Metabolism|February 24, 2018
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV studyShin-Ichi Harashima, Nobuya Inagaki, Kazuoki Kondo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2017
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional StudyAkiko Nishimura, Shin-Ichi Harashima, Haruna Fukushige, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Regulatory Toxicology and Pharmacology : RTP|January 25, 2006
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trialHideyuki Ikematsu, Kenjiro Nakamura, Shin-ichi Harashima, et al.
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 17, 2013
[Case report; a case of gastorinoma with subclinical insulinoma presenting repeated episodes of hypoglycemic attack]Kimitaka Shibue, Shin-Ichi Harashima, Yuji Nakamoto, et al.
Scientific Reports|April 12, 2017
Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretionYu Wang, Shin-Ichi Harashima, Yanyan Liu, et al.
Journal of Neuroscience Research|June 15, 2011
Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter releaseShin-ichi Harashima, Yu Wang, Takahiko Horiuchi, et al.
BMJ Case Reports|July 17, 2012
Marchiafava-Bignami disease-like lesions due to central nervous system lupusYoichiro Kashiwagi, Takahiko Horiuchi, Chie Harashima, et al.
Journal of Diabetes Science and Technology|October 3, 2015
Once Daily Self-Monitoring of Blood Glucose (SMBG) Improves Glycemic Control in Oral Hypoglycemic Agents (OHA)-Treated Diabetes: SMBG-OHA Follow-Up StudyShin-Ichi Harashima, Akiko Nishimura, Kaori Ikeda, et al.
Cardiovascular Diabetology|June 19, 2016
Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitusNobuya Inagaki, Shin-Ichi Harashima, Nobuko Maruyama, et al.
Journal of Diabetes Investigation|May 21, 2014
Sorting nexin 19 regulates the number of dense core vesicles in pancreatic β-cellsShin-Ichi Harashima, Takahiko Horiuchi, Yu Wang, et al.
Diabetes, Obesity & Metabolism|February 24, 2018
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV studyShin-Ichi Harashima, Nobuya Inagaki, Kazuoki Kondo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2017
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional StudyAkiko Nishimura, Shin-Ichi Harashima, Haruna Fukushige, et al.
Pageof 6